论文信息 - Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts. - 字舞流文

Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts.

E. Vellenga | A. A. van de Loosdrecht | G. Huls | A. Beeker | M. D. de Groot | O. de Weerdt | N. Veeger | L. Laterveer | C. Alhan | M. Hoogendoorn | J. Koedam | M. Kooy | L. H. van der Helm